Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.
Journal
Clinical diabetes : a publication of the American Diabetes Association
ISSN: 0891-8929
Titre abrégé: Clin Diabetes
Pays: United States
ID NLM: 8406985
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
19
8
2022
pubmed:
20
8
2022
medline:
20
8
2022
Statut:
ppublish
Résumé
Nonalcoholic fatty liver disease (NAFLD) is dramatically increasing in parallel with the pandemic of type 2 diabetes. Here, the authors aimed to assess the performance of the most commonly used noninvasive, blood-based biomarkers for liver fibrosis (FibroTest, NAFLD fibrosis score, BARD score, and FIB-4 Index) in subjects with type 2 diabetes. Liver stiffness measurement was estimated by two-dimensional shear wave elastography. Finally, the authors assessed the diagnostic role of ActiTest and NashTest 2 in liver fibrosis in the examined population.
Identifiants
pubmed: 35983425
doi: 10.2337/cd21-0104
pii: CD210104
pmc: PMC9331611
doi:
Types de publication
Journal Article
Langues
eng
Pagination
327-338Informations de copyright
© 2022 by the American Diabetes Association.
Références
Aliment Pharmacol Ther. 2016 Jan;43(1):83-95
pubmed: 26369383
Hepatol Res. 2016 Aug;46(9):862-70
pubmed: 26763834
Diabetes Metab. 2020 Sep;46(4):296-303
pubmed: 31786361
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Curr Diab Rep. 2007 Jun;7(3):175-80
pubmed: 17547834
J Hepatol. 2011 Jan;54(1):160-3
pubmed: 20934232
Arab J Gastroenterol. 2017 Jun;18(2):51-57
pubmed: 28579340
J Hepatol. 2003 Aug;39(2):222-30
pubmed: 12873819
PLoS One. 2020 Aug 21;15(8):e0236977
pubmed: 32822391
Diabetes Care. 2017 Mar;40(3):419-430
pubmed: 28223446
Gastroenterology. 2004 Feb;126(2):460-8
pubmed: 14762783
Diabetes Care. 2011 May;34(5):1139-44
pubmed: 21478462
J Hepatol. 2018 Feb;68(2):305-315
pubmed: 29154965
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):196-205
pubmed: 26907882
Clin Gastroenterol Hepatol. 2018 Apr;16(4):558-566.e2
pubmed: 29223443
Hepatology. 1999 Dec;30(6):1356-62
pubmed: 10573511
AJR Am J Roentgenol. 2020 Jan;214(1):W20-W26
pubmed: 31714842
J Clin Med. 2020 Apr 06;9(4):
pubmed: 32268517
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Int J Cancer. 2012 Apr 1;130(7):1639-48
pubmed: 21544812
J Gastroenterol Hepatol. 2019 Aug;34(8):1396-1403
pubmed: 30551263
BMC Gastroenterol. 2006 Feb 14;6:6
pubmed: 16503961
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Hepatology. 2013 Apr;57(4):1378-83
pubmed: 23213066
Diabetes Care. 2021 Feb;44(2):399-406
pubmed: 33355256
Gastroenterology. 1990 Nov;99(5):1396-400
pubmed: 2101588
BMC Gastroenterol. 2006 Nov 10;6:34
pubmed: 17096854
Ultrasound Med Biol. 2018 Dec;44(12):2419-2440
pubmed: 30209008
J Magn Reson Imaging. 2016 Feb;43(2):398-406
pubmed: 26201284
Diabetes Care. 2011 Mar;34(3):727-9
pubmed: 21278140
Diabetes Care. 2007 Nov;30(11):2940-4
pubmed: 17666460
J Investig Med. 2019 Feb;67(2):303-311
pubmed: 30309884
Hepatology. 2009 Jan;49(1):97-105
pubmed: 19053048
Am J Gastroenterol. 2013 Dec;108(12):1861-8
pubmed: 24100261
Radiology. 2015 Sep;276(3):845-61
pubmed: 26079489
Gastroenterology. 2005 Jun;128(7):1898-906
pubmed: 15940625
Hepatology. 2012 Sep;56(3):943-51
pubmed: 22505194
Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):461-478
pubmed: 29844588
J Hepatol. 2014 Feb;60(2):384-91
pubmed: 24512822
Hepatology. 2016 Jan;63(1):138-47
pubmed: 26171685
Ultraschall Med. 2018 Apr;39(2):e2-e44
pubmed: 29510439